UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 232.20
+4.20 (1.84%)
Nov 19, 2025, 3:24 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €43.32 billion as of November 19, 2025. Its market cap has increased by 23.82% in one year.
Market Cap
43.32B
Enterprise Value
44.59B
Revenue
6.85B
Ranking
n/a
PE Ratio
33.20
Stock Price
€232.20
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 43.32B, an increase of 4,763.68%. That is a compound annual growth rate of 13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 43.32B | 18.80% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | 15.96B | 19.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 48.26B |
| Financière de Tubize | 8.89B |
| Fagron NV | 1.50B |
| Ion Beam Applications | 295.59M |
| Onward Medical | 185.45M |
| Hyloris Pharmaceuticals | 168.00M |
| Nyxoah | 151.99M |
| Sequana Medical NV | 36.91M |